Given that previous studies have shown that NF-κB signaling pathway is crucial in tumor growth and drug resistance, we further explored the effect of the TRAF6/IRF3 axis on NF-κB-p65 in 5-FU-resistant GC cells, a key player in the NF-κB signaling pathway. The gene discussed is TRAF6; the disease is gastric cancer.